Michael DeBaun

(photo by Erin O. Smith)
December 4, 2025

Vanderbilt-Ingram researchers present cancer advancements at ASH 2025 

Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. 

By Tom Wilemon
Michael R. DeBaun, MD, MPH
August 19, 2025

Vanderbilt’s Michael R. DeBaun elected to American Academy of Arts and Sciences

This year, 247 members were elected from the mathematical, physical, biological, social and behavioral sciences, humanities, the arts, leadership, policy and communications.

By Bill Snyder
(iStock)
February 27, 2025

VUMC part of new study validating curative therapy for sickle cell disease

Of 38 adults with severe SCD who participated in the study, more than 97% no longer required immunosuppressive therapy one year after the transplant.

By Bill Snyder
June 25, 2024

International trial introduces another curative option for sickle cell disease 

The therapy, haploidentical bone marrow transplant with thiotepa and posttransplant cyclophosphamide, is as safe and more affordable than the recently FDA-approved myeloablative gene therapy and gene editing treatments.

By Jessica Pasley
Michael R. DeBaun, MD, MPH
February 29, 2024

Michael DeBaun receives Paragon Award from the Doris Duke Charitable Foundation

Vanderbilt’s Michael DeBaun, MD, MS, MPH, has received the Paragon Award for “Innovative Improvements to Clinical Care or Healthcare Delivery” from the Doris Duke Charitable Foundation (DDF).

By Nancy Humphrey
Michael DeBaun, MD, MS, MPH
March 24, 2022

VUMC’s DeBaun elected president-elect of the American Pediatric Society

Vanderbilt’s Michael DeBaun, MD, MS, MPH, has been elected president-elect of the American Pediatric Society.

By Nancy Humphrey
March 11, 2021

HBCU scholars program expanding enrollment

The James Puckette Carter Scholars Program, the result of a partnership between Meharry Medical College (MMC), Vanderbilt University Medical Center and the Burroughs Wellcome Fund (BWF), intended to increase the number of physicians who attended Historically Black Colleges and Universities (HBCUs) in health care, is expanding to double its enrollment capacity.
By Matt Schorr
July 29, 2019

DeBaun’s mentoring honored by American Society of Hematology

Michael DeBaun, MD, MPH, has been awarded the American Society of Hematology’s 2019 ASH Mentor Award for his sustained and outstanding commitment to the training and career development of early career hematologists.
By Christina Echegaray
February 22, 2017

Risk of death in sickle cell disease

Two factors commonly used to evaluate patients with sickle cell disease are associated with each other and can predict increased mortality, Vanderbilt researchers have discovered.
By Meredith Jackson
February 18, 2016

Pediatrics awarded physician-scientist training support

The National Institutes of Health (NIH) has awarded Vanderbilt’s Department of Pediatrics a K12 training grant to support early career faculty to become physician-scientists, the first time the department has received such an award.
By Matt Batcheldor
June 9, 2015

Retreat highlights pediatrics research at Vanderbilt

Every day, physicians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are looking for new and effective ways to care for their patients. Often that mission is carried out through clinical, basic and translational research across the institution and disciplines.
By Christina Echegaray
October 16, 2014

DeBaun’s Levi Watkins Lecture highlights the power of purpose

Throughout his career in medicine, Michael R. DeBaun, M.D., has found moments to fight the status quo.
By VUMC News and Communications
October 9, 2014

Vanderbilt’s DeBaun to deliver annual Levi Watkins Jr. Lecture

Michael R. DeBaun, M.D., J.C. Peterson Professor of Pediatrics and Medicine at Vanderbilt, will be the keynote speaker at the 13th Annual Levi Watkins Jr. Lecture.
By Jessica Pasley
1 2